Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000952015 | SCV001098480 | likely benign | Schuurs-Hoeijmakers syndrome | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001638020 | SCV001849623 | benign | not provided | 2019-12-19 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV000952015 | SCV002495883 | uncertain significance | Schuurs-Hoeijmakers syndrome | 2021-06-16 | criteria provided, single submitter | clinical testing | PACS1 NM_018026.3 exon 2 p.Val129Ile (c.385G>A): This variant has not been reported in the literature but is present in 0.002% (2/68022) of European alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/11-66193514-G-A?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:772455). This variant amino acid Isoleucine (Ile) is present in >20 species including mammals and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Prevention |
RCV003970734 | SCV004777501 | likely benign | PACS1-related disorder | 2020-02-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |